182 related articles for article (PubMed ID: 8700538)
1. Dimerization of a chimeric CD4-interferon-alpha receptor reconstitutes the signaling events preceding STAT phosphorylation.
Krishnan K; Yan H; Lim JT; Krolewski JJ
Oncogene; 1996 Jul; 13(1):125-33. PubMed ID: 8700538
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein.
Yan H; Krishnan K; Greenlund AC; Gupta S; Lim JT; Schreiber RD; Schindler CW; Krolewski JJ
EMBO J; 1996 Mar; 15(5):1064-74. PubMed ID: 8605876
[TBL] [Abstract][Full Text] [Related]
3. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
[TBL] [Abstract][Full Text] [Related]
4. The proximal tyrosines of the cytoplasmic domain of the beta chain of the type I interferon receptor are essential for signal transducer and activator of transcription (Stat) 2 activation. Evidence that two Stat2 sites are required to reach a threshold of interferon alpha-induced Stat2 tyrosine phosphorylation that allows normal formation of interferon-stimulated gene factor 3.
Nadeau OW; Domanski P; Usacheva A; Uddin S; Platanias LC; Pitha P; Raz R; Levy D; Majchrzak B; Fish E; Colamonici OR
J Biol Chem; 1999 Feb; 274(7):4045-52. PubMed ID: 9933596
[TBL] [Abstract][Full Text] [Related]
5. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
6. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling.
Li X; Leung S; Kerr IM; Stark GR
Mol Cell Biol; 1997 Apr; 17(4):2048-56. PubMed ID: 9121453
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction.
Yan H; Krishnan K; Lim JT; Contillo LG; Krolewski JJ
Mol Cell Biol; 1996 May; 16(5):2074-82. PubMed ID: 8628273
[TBL] [Abstract][Full Text] [Related]
8. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
9. Stat2 binding to the interferon-alpha receptor 2 subunit is not required for interferon-alpha signaling.
Nguyen VP; Saleh AZ; Arch AE; Yan H; Piazza F; Kim J; Krolewski JJ
J Biol Chem; 2002 Mar; 277(12):9713-21. PubMed ID: 11786546
[TBL] [Abstract][Full Text] [Related]
10. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.
Colamonici O; Yan H; Domanski P; Handa R; Smalley D; Mullersman J; Witte M; Krishnan K; Krolewski J
Mol Cell Biol; 1994 Dec; 14(12):8133-42. PubMed ID: 7526154
[TBL] [Abstract][Full Text] [Related]
11. Direct signal transduction via functional interferon-alphabeta receptors in CD34+ hematopoietic stem cells.
Giron-Michel J; Weill D; Bailly G; Legras S; Nardeux PC; Azzarone B; Tovey MG; Eid P
Leukemia; 2002 Jun; 16(6):1135-42. PubMed ID: 12040445
[TBL] [Abstract][Full Text] [Related]
12. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
[TBL] [Abstract][Full Text] [Related]
13. Constitutive STAT1 tyrosine phosphorylation in U937 monocytes overexpressing the TYK2 protein tyrosine kinase does not induce gene transcription.
Eilers A; Kanda K; Klose B; Krolewski J; Decker T
Cell Growth Differ; 1996 Jun; 7(6):833-40. PubMed ID: 8780896
[TBL] [Abstract][Full Text] [Related]
14. Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol.
Su L; David M
J Biol Chem; 2000 Apr; 275(17):12661-6. PubMed ID: 10777558
[TBL] [Abstract][Full Text] [Related]
15. Intracellular domain of the IFNaR2 interferon receptor subunit mediates transcription via Stat2.
El Fiky A; Arch AE; Krolewski JJ
J Cell Physiol; 2005 Aug; 204(2):567-73. PubMed ID: 15717316
[TBL] [Abstract][Full Text] [Related]
16. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.
Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE
Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853
[TBL] [Abstract][Full Text] [Related]
17. Definition of the interferon-alpha receptor-binding domain on the TYK2 kinase.
Yan H; Piazza F; Krishnan K; Pine R; Krolewski JJ
J Biol Chem; 1998 Feb; 273(7):4046-51. PubMed ID: 9461596
[TBL] [Abstract][Full Text] [Related]
18. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes.
Beadling C; Guschin D; Witthuhn BA; Ziemiecki A; Ihle JN; Kerr IM; Cantrell DA
EMBO J; 1994 Dec; 13(23):5605-15. PubMed ID: 7988557
[TBL] [Abstract][Full Text] [Related]
19. Impaired type I IFN-induced Jak/STAT signaling in FA-C cells and abnormal CD4+ Th cell subsets in Fancc-/- mice.
Fagerlie SR; Koretsky T; Torok-Storb B; Bagby GC
J Immunol; 2004 Sep; 173(6):3863-70. PubMed ID: 15356134
[TBL] [Abstract][Full Text] [Related]
20. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses.
Kohlhuber F; Rogers NC; Watling D; Feng J; Guschin D; Briscoe J; Witthuhn BA; Kotenko SV; Pestka S; Stark GR; Ihle JN; Kerr IM
Mol Cell Biol; 1997 Feb; 17(2):695-706. PubMed ID: 9001223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
